Form 4: Labcorp Director Kathryn E. Wengel Reports Acquisition of Restricted Stock Units

Kathryn E. Wengel, a director of Labcorp Holdings Inc., reported the acquisition of 897 restricted stock units on February 11, 2025, vesting fully on February 11, 2026.

Summary

• Kathryn E. Wengel, a director at Labcorp Holdings Inc., filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on February 11, 2025.
• Wengel acquired 897 Restricted Stock Units (RSUs) representing the contingent right to receive one share of Labcorp Holdings Inc. Common Stock per unit.
• The RSUs vest fully on February 11, 2026.
• The reporting person directly owns 897 derivative securities after the reported transaction.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it's a standard regulatory filing. The acquisition of RSUs is a moderately positive signal, suggesting confidence from a company director, but it's not a major event.

Positives

• The acquisition of RSUs by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of the RSUs in February 2026 suggests a continued relationship between the director and the company.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency regarding the holdings of company insiders.

Stakeholder Impact

• The acquisition of RSUs by a director can have a slightly positive impact on shareholders, as it aligns the director's interests with those of the shareholders.

Key Dates

Keywords

Form 4, Restricted Stock Units, LABCORP HOLDINGS INC., Director, Beneficial Ownership, Acquisition, LH, Wengel